May 5, 2013
LDK378, Novartis Boost Seen in Fast Approvals as Protection Ends
Washington Post with Bloomberg

April 22, 2013
LGX818, Made to Fight Melanoma
Carmen Drahl, Chemical and Engineering News

April 4, 2013
Intermittent treatment with vemurafenib may prevent lethal drug resistance in melanoma
Medical Xpress

March 22, 2013
Bizarre New Virus Behind a Century-Old Mystery Disease
Ed Yong, National Geographic

March 21, 2013
Novartis CEO Joe Jimenez lays out his path to business longevity ( R & D discussed)
Geoff Colvin, Fortune, CNN Money

March 19, 2013
Virus behind hepatitis in horses identified
HorseTalk

March 18, 2013
Distinctive virus behind mystery horse disease
Ed Yong, Nature

March 5, 2013
Africa's first study site, in SA, will boost medical research
Business Report of South Africa, Londiwe Buthelezi

March 4, 2013
Novartis Encouraged by typhoid vaccine progress
Nick Paul Taylor, Fierce Vaccines

February 28, 2013
Novartis launches effort to fight heart disease in Zambia
Fox Business News

February 28, 2012
Novartis Collaboration Aims to Eliminate Rheumatic Heart Disease
Africa Business Wire

Feb. 16, 2013
Mural on Mass. Ave.
M. Holbrow, CCTV

February 2013
Most Innovative Pipeline: Novartis
MedAdNews, Andre Humphreys

January 30, 2013
Better connected
Mark Fishman, Robert Cross & Brigitta Tadmor

January 29, 2013
Research prize boost for Europe (Mark Fishman quoted)
Nature

January 9, 2013
Drug-resistant melanoma tumors in mice shrink when therapy is interrupted (Postdoc paper)
Medical Express

January 9, 2013
"Drug Holidays" beat cancer drug resistance in mice
BBC

January 1, 2013
Biotech Players Lead a Boom in Cambridge
Karen Weintraub, The New York Times